Technology | October 29, 2010

New Radiation Therapy Solutions Launched at ASTRO

October 29. 2010 – The company D3 Radiation Planning has changed its name to D3 Radiation Oncology Solutions. The company chose its new name to reflect the recent expansion in the number of new solutions that D3 offers to accelerate excellence in radiation oncology.

"The future of radiation oncology belongs to those practices that recognize and address changes and challenges in the field today," said Kathy Lokay, president and CEO, D3 Radiation Oncology Solutions. "Continuing to build on our affiliation with UPMC and UPMC Cancer Centers, D3 has new solutions to help practices achieve and sustain excellence – in quality, safety, efficiency, and outcomes."

D3's new suite of solutions, which will be launched at the upcoming ASTRO Annual Meeting in San Diego, includes:

• D3 Radiation Oncology Pathways: The pathway solution for radiation oncology is developed and maintained by a distinguished group of academic and community radiation oncologists. D3 Radiation Oncology Pathways provide treatment recommendations for each unique patient presentation in a Web-based interactive decision support tool. In an era of increased payer scrutiny over the appropriateness of utilization and costs of cancer care, D3 Radiation Oncology Pathways help practices prove their quality and avoid external administrative oversight.

• D3 Quality Assurance and Peer Review Programs: These solutions support practices to ensure quality and patient safety, differentiate themselves in their market, and prepare to achieve American College of Radiology (ACR) or American College of Radiation Oncology (ACRO) accreditation.

• Flexible Options for Treatment Planning: D3 now offers practices with multiple locations and high patient volume assistance in establishing their own centralized treatment planning centers of excellence. D3 also continues to offer On-Demand Dosimetry to centers experiencing short- or long-term dosimetry staff vacancies. D3's expertise in treatment planning is unsurpassed. Since 2001, D3 has developed more than 20,000 treatment plans.

• Clinical Training: D3's experienced, ABR board certified and clinically active medical physicists and dosimetrists work in collaboration with practices to accelerate and optimize the application of advanced technologies through hands-on operations and clinical training coupled with extensive post-training validation and peer review.

• Commissioning: Whether fully outsourced or facilitated, D3's commissioning solutions are performed in a consultative manner with a rigorous methodology from acceptance testing and data collection to modeling and validation. And D3 now has experience commissioning Varian TrueBeam.

"Our clinical staff has an average of 20 years of radiation oncology experience, and since 2001 we have supported more than 250 practices in the U.S. and internationally," said Greg Ross, chief operating officer, D3 Radiation Oncology Solutions. "With the D3 suite of solutions, we are applying our expertise and experience to help practices be successful as they face today's intensifying demands for quality, safety and efficiency."

D3 Radiation Oncology Solutions is exhibiting at the American Society for Radiation Oncology (ASTRO) Annual Meeting at the San Diego Convention Center, Oct. 31 – Nov. 3, 2010. D3 will be at booth 121.

For more information: www.d3rad.com

Related Content

ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init